Recombinant bovine basic fibroblast growth factor gel formulation (EssexBio)

重组牛碱性成纤维细胞生长因子外用凝胶 (珠海亿胜)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRecombinant bovine basic fibroblast growth factor gel formulation (EssexBio)
Drug Alias Name重组牛碱性成纤维细胞生长因子凝胶Beifuji (EssexBio)Recombinant bovine basic fibroblast growth factor (EssexBio)rb-bFGF (EssexBio)贝复新
ClassificationBiologics
Mechanisms of ActionFibroblast growth factor receptors modulators
TargetsFibroblast growth factor receptors
Therapy Area/IndicationsWounds and Injuries
Global Approved IndicationsWounds and Injuries
Approved Indications in ChinaWounds and Injuries
Original Approved Country/TerritoryMainland China
Original Approved Date2004/01/08
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesZhuhai Essex Bio-Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesZhuhai Essex Bio-Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsWounds and Injuries
Inactive IndicationsN/A

Other Information

ATC CodeD03
Related LinksN/A